Premium
Diabetes caused by Kir6.2 mutation: Successful treatment with oral glibenclamide switched from continuous subcutaneous insulin infusion in the early phase of the disease
Author(s) -
Nagano Nobuhiko,
Urakami Tatsuhiko,
Mine Yusuke,
Watanabe Hirofumi,
Yoshida Ayako,
Suzuki Junichi,
Saito Hiroshi,
Ishige Mika,
Takahashi Shori,
Mugishima Hideo,
Yorifuji Tohru
Publication year - 2012
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/j.1442-200x.2011.03413.x
Subject(s) - medicine , pediatrics , glibenclamide , family medicine , diabetes mellitus , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom